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A B S T R A C T
Introduction. Adolescents and young adults aged 15–39 years who have been diagnosed with cancer (AYAC) have
unique medical and psychosocial needs. Following their cancer treatments, AYAC must learn to manage the
sometimes irreversible general side effects of cancer treatments including side effects that impact their sexuality.
These side effects include but are not limited to: infertility, altered body/physical appearance, and sexual dysfunction.
Such effects may hinder AYAC efforts to date and experiment sexually, limiting sexual maturation and conﬁdence, as
well as the formation or maintenance of meaningful couple and sexual relationships. It is clear that we need to tailor
our clinical approaches to ensure that we assess the unique needs and concerns faced by AYAC.
Aims. Based on consistent study ﬁndings substantiating the distinctive needs of AYAC, the main objective of this
article is to present the core clinical components involved in assessing sexuality among AYAC.
Methods. The clinical recommendations are based on the authors and experts’ clinical experiences coupled with a
thorough examination of the literature related to AYAC sexuality.
Main OutcomeMeasures. This article ﬁrst describes the three components (clinical interview, review of chart notes,
and self-report questionnaires) of a sexuality assessment and the seven core domains that highlight target areas of
focus.
Results. A detailed outline of each of the core domains of assessment (socio-demographics; medical history; fertility
and sexually transmitted infection; sexual functioning; sexual coping style; body and self-image; and sexual history
and dating/couple experience) is presented. A “toolbox” table containing useful resources for clinicians (e.g.,
questionnaires and red ﬂags) and direct resources for AYAC patients are included.
Conclusion. Cancer can have a signiﬁcant impact on numerous domains of AYAC sexuality. The assessment of and
attention to the impact of sexuality on AYAC is crucial in order to provide effective and comprehensive quality
patient cancer care. Aubin S and Perez S. The clinician’s toolbox: assessing the sexual impacts of cancer on
adolescents and young adults with cancer (AYAC). Sex Med 2015;3:198–212.
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Introduction
The 2013 LIVESTRONG and Institute ofMedicine Workshop deﬁnes adolescents and
young adults with cancer (AYAC) as individuals
aged 15–39 years who have been diagnosed with
cancer [1]. These individuals present unique
medical and psychosocial needs that distinguish
them from both younger and older cancer groups
[1–6]. Studies conﬁrm the disruptive impact of
cancer on the achievement of critical developmen-
tal milestones associated with adolescence and
emerging adulthood [1,7,8]. AYAC are at risk of
experiencing delays or arrests in their sexual devel-
opment that often include decreased or non-
existent sexual experimentation and discovery.
AYAC are not only faced with the pressure of
“catching up with life,” but are also faced with a
number of added challenges pertinent to their sexu-
ality [9].
The literature emphasizes the importance of a
sexuality assessment in cancer populations as a
valuable and essential opportunity to provide com-
prehensive cancer care [10,11]. Nonetheless, sexu-
ality remains a topic that clinicians rarely inquire
about with cancer patients [12,13]. Sted et al.
report that only one of four doctors and one of ﬁve
nurses actually discuss sexual issues with ovarian
cancer patients [14]. Similarly, Park et al. found
that 62% of primary care physicians reported that
they “never” or “rarely” address sexual dysfunction
with their cancer patients, and 54% reported that
they are “not at all likely” or “a little likely” to
initiate conversations about sexual dysfunction
with their patients [15].
There are numerous contributing factors for
why sexuality is rarely discussed by clinicians with
AYAC, which can include: (i) the clinician’s own
embarrassment and fear (e.g., worries about inva-
sion of privacy or legal consequences), (ii) the belief
that sexuality is deﬁned solely as sexual function
[16], (iii) the belief that sexuality is not part of the
presenting problem (cancer), and (iv) the clinician’s
own lack of training in assessing sexuality [16,17].
Similar to professionals, cancer patients also
report that they seldom remember discussing
sexual risks pre-treatment or treatment options for
sexual dysfunction post-treatment. Some of the
barriers for patients include: (i) their own discom-
fort and embarrassment, (ii) time constraints
during medically oriented visits, (iii) not being
prompted or having the medical professional ini-
tiate the discussion, and (iv) a sense of hopeless-
ness, helplessness, and/or pessimism that the
sexual problem can be resolved or that interven-
tions exist to help with their sexual difﬁculties
[10,13,14]. Thus, sexuality is often overlooked or
under-prioritized among cancer patients [16,17].
Such challenges are more pronounced with
AYAC as the main focus is often on the young
adults’ survival. The confrontation with mortality
is extremely foreign and unexpected for this age
group that sexuality often gets “swept under the
rug” as one of the last priorities worthy of attention.
Most of the literature examining sexuality and
sexual health (herein referred to as sexuality) for
AYAC comes from breast and gynecological cancer
survivors and/or older adults (40+). Less is known
about how clinicians working with AYAC (males
and females, with all cancers) can effectively assess
and evaluate their sexuality needs [18]. To the best
of our knowledge, a sexuality assessment tailored
for the AYAC population has not been described.
Clinicians working with AYAC need to adapt their
clinical evaluations to ensure that the unique sexu-
ality concerns and needs are appropriately assessed
and addressed among the AYAC population.
The goal of this article is to present useful and
validated clinical information on key areas of focus
when assessing AYAC sexuality. In addition, the
authors highlight “red ﬂag” tips that practitioners
should keep in mind when assessing the sexuality
of AYAC. These clinical recommendations are
based primarily on the clinical experiences of the
ﬁrst author and consultation with experts in the
ﬁeld, coupled with a thorough examination of the
literature related to AYAC sexuality. The article
provides a toolbox of useful resources (e.g., self-
report questionnaires, readings, and patient
resources) to assist clinicians working with AYAC
in the context of sexuality.
The authors ﬁrst provide a framework and con-
ventional format for assessing AYAC sexuality (i.e.,
clinical interview, review of chart notes, and ques-
tionnaires). Second, the authors outline seven core
domains believed to be necessary for completing a
thorough sexuality assessment with AYAC. Ulti-
mately, a comprehensive and appropriate sexuality
assessment will allow for improved allocation and
provision of resources to AYAC.
Clinical Framework
The present sexuality assessment among AYAC
follows the clinical guidelines and recommenda-
tions provided by the Adolescent and Young
Adult Oncology Progress Review Group of the
LIVESTRONG Young Adult Alliance (renamed
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Critical Mass), the Canadian Task Force on Ado-
lescents and Young Adults, the July 2013
LIVESTRONG and Institute of Medicine Work-
shop and research conducted by Fernandez
et al. [1,2,19–24]. These AYAC-speciﬁc guidelines
follow existing models of sexuality from outside
oncology such as the extended version of Annon’s
Permission, Limited Information, Speciﬁc Sug-
gestions, and Intensive Therapy (PLISSIT) model
and the Ex-PLISSIT model [10,25,26]. Moreover,
Woods’ [27] series of questions to assess sexuality,
which was revised and expanded on to apply spe-
ciﬁcally to the oncology population, was also used
as the clinical framework [17,28,29].
The age range of AYAC as deﬁned by the
National Cancer Institute is 15–39 years [6,23]. In
order to best account for the differential physi-
ological and psychosocial realities experienced by
AYAC, the authors have elected to sub-divide this
range into three age cohorts: late adolescence
(15–18 years old), early young adulthood (19–24),
and late young adulthood (25–39) [30]. Setting age
cutoffs is difﬁcult as the range is inﬂuenced by
gender, culture, time of diagnosis, and each
patient’s unique maturation [6]. Most of the issues
herein apply broadly to all AYAC (the entire 15–39
age range). When a particular issue is relevant or
applicable to a speciﬁc cohort, the authors will
delineate that speciﬁc group.
Format of a Sexuality Assessment with AYAC
The topic of sexuality is both infrequently con-
sidered and challenging for health-care providers
to address with AYAC [13,15,31]. Thus, the style
and format of the assessment require the clinician
to have the necessary skills to maintain the
delicate balance between sexual investigation
(e.g., asking questions) and ensuring the AYAC
comfort and conﬁdentiality. In order to conduct a
comprehensive sexuality assessment for AYAC,
the following format is recommended: 1. Clinical
Interview, 2. Chart Review of clinical reports, and
3. Self-report questionnaires.
1. Clinical Interview
The clinical interview is the primary source of
information about anAYAC’s sexuality. It allows for
the identiﬁcation of appropriate questionnaires for
subsequent use and ultimately facilitates appropri-
ate interventions. The clinician should use direct,
open-ended, non-judgmental questions, engaging
the AYAC via direct eye contact while trying to
build a mutually interactive and dynamic relation-
ship. Someopening questions can include:Howhas
your cancer diagnosis or treatment affected the way
you see yourself as a young man/woman/sexual
being; as a single teen or young adult who dates and
interacts with potential partners?; as a wife/
husband/partner?; What aspects of your sexuality
do you believe have been affected by your cancer
diagnosis or treatment (negative or positive
aspects)?; and How important is sexual intimacy to
you [17]?
It is also essential to initially legitimize and nor-
malize the sexuality discussion by making the con-
versation feel like a routine part of the clinic. The
clinician can emphasize the importance of accu-
rately assessing beliefs and concerns about sexual-
ity. One of the best methods of beginning a
discussion of this difﬁcult and sensitive topic is to
begin with a comment such as “When I am talking
with any adolescent or young adult diagnosed with
cancer or treated with (whatever treatment or
medication that may impact sexuality), I usually
ask about sexuality.” Following this opening
comment, the clinician can focus the interview
questions on the speciﬁc areas identiﬁed in either
the questionnaire, the referral, or any area that is
identiﬁed by a few subsequent direct questions
that the clinician understands to be problematic or
distressing to the AYAC.
The style and role of the clinician that AYAC
best respond to is the mentorship/life coach inter-
vention approach, which includes collaborating,
goal setting, problem solving, sharing information,
afﬁrming, conﬁdence building, and supporting.
This approach integrates the principles of
cognitive-behavioural and solution-focused inter-
ventions that foster a balance between teamwork
and autonomy among the clinician and the AYAC
[32]. This was consistently observed by the ﬁrst
author during her clinical work and preliminary
study ﬁndings [33]. It is also important that clini-
cians are aware, examine, and appropriately
manage their own beliefs, attitudes, and biases,
such as sexism, ageism, or alternative sexual prac-
tices, which can affect the clinician’s ability to
address sexuality with AYAC [17,34].
Many AYAC are routinely accompanied by
parents during theirmedical visits [1]. As such, they
may be quite concerned that information discussed
in the assessment will be disclosed to their parents.
This may be especially true for the early and late
young adulthood cohorts. The authors stress the
importance that clinical interviews be conducted in
private with the AYAC, rather than with parent(s)
present [31,35]. Adolescence and emerging early
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young adulthood is often characterized as an
intense process of physical and emotional develop-
ment, coupled with the formation of close bonds
with peer groups and the separation from parental
authority. For this reason, the authors believe that a
separate interview is needed to allow the AYAC to
discuss private, intimate topics.
Providing AYAC with a “safe place” to discuss
their sexuality without their parents present fosters
trust between the patient and the clinician. One
potential pitfall is the parent of the adolescent or
early young adult who refuses to leave the room.
With respect to the parent, the clinician can high-
light that, regardless of the cancer, sexuality, and
fertility are notoriously difﬁcult issues for any
young person to discuss with parental or authority
ﬁgures present. An alternative solution is to reas-
sure parents that although adolescents are more
likely to disclose sensitive health topics if they are
given assurance of conﬁdentiality, these assurances
seem not to impact the teens’ later discussions of
these issues with their parents [36,37].
Although this might be different from other
oncology appointments, it is necessary to establish
boundaries with family members during the initial
assessment. Coupled with this, reassuring the
AYAC about patient conﬁdentiality (e.g., informa-
tion will not be shared with other professionals,
unless permission is granted). With respect to con-
ﬁdentiality, the use of electronic medical records
(EMRs) creates novel opportunities for improve-
ments in healthcare, but also carries the unfore-
seen potential for inadvertent breaches of
conﬁdentiality. Security measures and appropriate
safeguards should be put in place at the systems
level to prevent breaches of patient conﬁdentiality,
as EMRs may actually offer more security than
traditional paper-record systems.
Particularly for the early young adulthood and
young adulthood cohort, sexuality may be a topic
that they have infrequently or never been asked
about during their cancer care. The ﬁrst author
has noted that it is not uncommon for younger
AYAC to have less sexual knowledge or to have
engaged in less sexual experimentation than their
aged-matched peers [18,38]. Therefore, although
the clinician will ask numerous questions during
the assessment, the clinician should create an envi-
ronment in which the AYAC should feel equally
comfortable to ask questions. Strategies to
increase the AYAC’s comfort include normalizing
that sexuality is often an issue discussed by other
AYAC, ensuring conﬁdentiality, building rapport,
and sharing with the AYAC that he or she is invited
to ask any questions. The assessment can act as a
space for the clinician to respond to the AYAC’s
needs as well as an opportunity to provide some
initial psycho-education to the AYAC.
With regard to logistics, the authors found that
AYAC were most receptive to varying the timing
and format of the meetings than conventional
assessment. For example, having appointments
later in the evening, and the opportunity to
combine face-to-face meetings with other forms of
interviews that would not require them to travel to
the clinic/hospital. The ﬁrst author has noted that
AYAC generally appreciated the use of technologi-
cal means (e.g., Skype—a video teleconferencing
platform where the clinician and the AYAC can see
one another) to facilitate meetings and allow
for a more ﬂexible relationship. Table 1 provides
summary recommendations for the clinical
interview.
2. Chart Review of Clinical Notes/Reports
Medical charts are excellent resources that can be
used in conjunction with interviews for clinicians
working with AYAC. These charts are a vital
source of information given that they include
reports from not only the oncology care team, but
also from professionals whose expertise is highly
relevant to sexuality (e.g., gynecologist, urologist,
and couple/sex therapist). These reports can assist
the clinician in identifying both medical and psy-
chosocial factors that impact sexuality (e.g., rule
out medical etiologies for sexual dysfunctions).
3. Self-Report Questionnaires
Utilizing self-report questionnaires as a compli-
ment to the interview and chart review can provide
many beneﬁts, especially in circumstances where
time is coveted. Numerous instruments [39] are
available for general assessment of the ability to
Table 1 Key points for conducting a clinical interview
with AYAC
✓ Use a direct, open, non-judgmental, interactive communication
style
✓ Utilize a mentorship/life coach approach, balancing teamwork
and autonomy
✓ Meet AYAC alone as opposed to with their parents
✓ Ensure confidentiality of information, highlighting that nothing
will be shared with parents and/or other team members
(unless permission is granted by AYAC)
✓ Allow AYAC to ask questions, and clinicians can provide
psycho-education
✓ Validate and normalize AYAC concerns that may be related to
sexual inexperience
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function sexually, level of sexual satisfaction, and
evaluation of sexual beliefs and values such as the
Derogatis Sexual Functioning Inventory [40,41]
and Global Sexual Functioning [39]. There are
also many instruments designed speciﬁcally to
assess sexuality in men and in women that can be
found through the Patient-Reported Outcome
and Quality of Life Instruments Database
(PROQOLID) website [42].
A recent systematic review of questionnaires
used in psychosocial oncology indicated that very
few were validated using AYAC and none were
speciﬁc to the area of sexuality [43]. Suggested
questionnaires related to each core domain of
assessment are provided in Table 2. The authors
have made every attempt to choose questionnaires
that are either empirically validated (i.e., extensive
psychometric validation) with a cancer population
[54–60,72,73] and/or AYAC population [43,45,46],
or which the authors believe to be clinically appro-
priate (and if possible, supported by applied
research) to assess sexuality among AYAC.
Core Domains for Assessing Sexuality with AYAC
Given the complex interplay between an AYAC’s
sexuality and his or her mental and physical health,
it is important that sexuality assessments are not
conducted in isolation. The following domains
may be best understood as contributing variables
that can either inﬂuence or maintain sexual func-
tion, adjustment, and relationship difﬁculties.
Sexuality assessments should be considered a
crucial element for a better understanding of an
AYAC overall life functioning.
The authors will present seven core domains
that they suggest need to be thoroughly evaluated
in any comprehensive AYAC sexuality assessment:
I. Socio-Demographics
The sexuality assessment should be considered in
the context of a variety of socio-demographic
factors, such as age, gender, and relationship
status. The existential reality and needs of younger
vs. older, male vs. female, as well as single vs.
coupled AYAC may signiﬁcantly differ [74]. The
authors suggest beginning the sexuality assessment
by assessing the patient’s socio-demographics
(e.g., age, culture, ﬁnancial, relationship status,
family, and social support). This is often important
because distinct socio-demographics can result in
certain developmental interruptions (e.g., identi-
fying and pursuing a vocational goal) that have
meaningful consequences on the AYAC growth
[18]. As an example, the development of setbacks
in the ﬁnancial independence of early young adult-
hood AYAC may have multiple repercussions,
including moving back home with one’s parents.
This may not only be hard on AYAC self-image/
esteem but also compromise the desire of the
single AYAC to date and experiment sexually.
Furthermore, being a member of a sexual
minority exposes AYAC to a higher risk of emo-
tional distress and isolation, including an increase
in suicidal risk [75]. For these AYAC, the risk may
be twofold: (i) identifying as a young adult with
cancer or cancer survivor, and (ii) identifying as
part of a sexual minority [76]. These two factors
likely compound to further increase the risk for
distress. Special attention should be paid to assess-
ing the sexual as well as the emotional repercus-
sions of cancer for AYAC who identify as part of
the sexual minority population.
For lesbian, gay, bisexual, transgender, and
queer individuals (LGBTQ) living with cancer,
sexual orientation introduces unique challenges,
particularly when considering discrimination and
other healthcare-related inequities that are rou-
tinely experienced by many LGBTQ individuals
[77]. Providers may be less likely to address sexu-
ality and sexual healthcare due to discomfort and
lack of knowledge about the sexual practices and
needs of the population, particularly with
transgendered individuals [78]. Issues for LGBTQ
living with cancer include but are not limited to: (i)
LGBTQ wariness of the healthcare system due to
past experience with stigma, (ii) pressure to adhere
to gender expectations, (iii) clinician assumes het-
erosexuality as orientation, and (iv) clinician lacks
respect for LGBTQ support system (e.g., partners
who have been together for many years but are not
legally married). As such, there is a need to being
culturally responsible and competent with unique
populations. This involves approaching all AYAC
with appropriate, nonheterosexist language [76].
Training for healthcare providers to provide more
culturally competent, safe, and welcoming care is
available from the National LGBT Cancer
Network [44].
II. Medical History
A comprehensive assessment of an AYAC medical
history (i.e., during the interview combined with
the chart review) further adds to a comprehensive
picture of the AYAC sexuality. In the assessment,
the clinician must conceptualize where the patient
identiﬁes on the cancer trajectory (i.e., at diagno-
sis, during or post-treatment, survivorship). In
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Table 2 Red flags and selected clinician and patient resources for core domains of AYAC sexuality assessment
Core domain Key tips/red flags Resources for clinician Resources for patient
I. Socio-
demographics
Contextualize sexual impact as a
function of socio-demographics
(e.g., age, culture, family, single
or couple)
Consider financial factors and
changes in living situation that
impact sexuality (e.g., moving
back home with parents)
Assess and consider sexual
orientation
Use appropriate, non-heterosexist
language to ensure cultural
responsibility and competency
National LGBT Cancer Network
[44].
www.youngadultcancer.ca/
our-stories/#links†
http://www.huffingtonpost.com/
news/generation-why/‡
shannonstoolbox.com/cancer/
www.canteen.org.au
Cancer in Young Adults: Through
Parent’s Eyes: http://
www.cancerinyoungadults
-throughparentseyes.org/home
http://www.cancer.gov/types/aya
(see organizations serving AYAs
such as planet cancer and stupid
cancer.org)
II. Medical
History
Comprehensive inquiry of AYAC
medical history (e.g., history of
cancer diagnosis/recurrence,
concomitant illnesses’ treatment
with medications)
Examine sexuality within the
context of patients’ mental and
physical health (e.g., ability to
engage and meet daily activities)
Consider HRQL
Quality of Life-Cancers
Survivors** [45] and Peds QL*
[46]
Functional Assessment of Cancer
Therapy—General (FACT-G)**
[47]
III. Fertility
and STIs
Review clinical notes/reports from
fertility specialists
Assess psychosocial impacts of
loss/compromised fertility
Consider desirability as a potential
partner, grief concerning biological
parenthood, low/poor self-esteem,
threat to the formation/survival of
couple relationships
Referral to specialist to determine
current reproductive functioning (if
unknown)
Educate about safe sex practices
(e.g., contraception, STIs, HPV
vaccination)
Fertility Quality of Life Tool
(FertilQol) [48]
[49]: excellent source on infertility
and reproductive health issues
for AYAC, e.g., fertility
preservation options
for males and females,
contraception, pregnancy,
nontraditional family planning
[50–53]
Information on sexuality and
reproductive issues
(PRD®)—Health Professional
Version–National Cancer Institute:
http://www.cancer.gov/
cancertopics/pdq/supportivecare/
sexuality/HealthProfessional
Fertile Hope for health
professionals http://
www.fertilehope.org/
healthcare-professionals/
index.cfm
Information on sexuality and
reproductive issues
(PDQ®)—Patient
Version—National Cancer
Institute: http://www.cancer.gov/
cancertopics/pdq/supportivecare/
sexuality/Patient
Fertility Hope referral guide http://
www.fertilehope.org/tool-bar/
referral-guide.cfm
http://www.cancer.gov/
cancertopics/causes-prevention/
risk-factors/infectious-agents/
hpv-vaccine-fact-sheet
Hope for Two: The Pregnant with
Cancer Network: http://
www.pregnantwithcancer.org and
http://www.livestrong.org/
we-can-help/fertility-services/
IV. Sexual
Functioning
Assess direct impacts of
treatment (e.g., chemotherapy,
surgery) on sexual functioning
Special attention directed at
negative impacts of treatments on
genito-urinary, pelvic, or hormonal
areas
Consider common sexual
complaints such as issues related
to desire, arousal, orgasm, pain
during intercourse
Referral to specialists (e.g.,
gyno-oncologist, uro-oncologist) to
rule out medical etiology of sexual
complaints
[52,53]
Chapter 2 for an overview;
Chapters 4–12 for treatment
related side effects for specific
cancer sites cancers [10]
Range of Sexual Function and
satisfaction scales [39–43]
Female Sexual Function Index**
[54]
UCLA Prostate Cancer Index**
[55], and its longer version** [56],
the Expanded Prostate Index
Composite (EPIC) [57]
the International Index of Erectile
Function (IIEF)** [58] and its
shorter version, the IIEF-5** [59]
Sexual function—Vaginal changes
Questionnaire (SVQ)** [60]
Menopause Guidebook [61]
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addition, special attention should be paid to:
history of cancer diagnosis(es) and recurrence;
treatment(s) and medications; and concomitant
illness’ treatment(s) with medications, as these
may have a direct impact on AYAC fertility and
sexual response.
Furthermore, health-related quality of life
(HRQL) features an importantmedical correlate of
sexuality due to the negative effect that some
HRQL areas have on sexual function and well-
being. The HRQL areas that may inﬂuence sexu-
ality range from physical function to mental health
and relationship issues, reﬂecting the multifaceted
impacts of cancer [47,79]. The clinicianmust assess
for the presence and severity of common side
effects such as fatigue, loss of energy, insomnia, and
nausea and their relationshipwith sexuality.HRQL
may be assessed using the Quality of Life-Cancer
Survivors (QOL-CS) [45], the only validated
instrument using AYAC as the population sample.
III. Fertility and Sexually Transmitted Infections (STIs)
Fertility is a signiﬁcant source of concern and dis-
tress for the majority of AYAC and is highly recom-
mended as a part of a comprehensive sexuality
assessment. Managing the effects of cancer treat-
ment on fertility can be as emotionally painful as
the cancer itself [4,9]. Compromised fertility was
found to signiﬁcantly threaten youngwomen’s self-
esteem, as well as men’s mental/emotional health
Table 2 Continued
Core domain Key tips/red flags Resources for clinician Resources for patient
V. Sexual
Coping
Style
Assess the short vs. long-term
repercussions of sexual
avoidance for AYAC
Assess use of substances to
alleviate sexual anxiety or
enhance sexual performance
Inform AYAC about the effect of
drugs/alcohol on sexuality
[62,63]
VI. Body and
Self
Image
Assess changes to physical
appearance that can impact
self-esteem, sexual assertiveness,
sexual experimentation, and
significant sexual/couple
experience
Assess AYACs’ frame of mind
during sex
Inquire about “sexual
hypervigilence” to any affected
areas
Body Image Scale [64]
Sexuality Scale [65]
Sexual Beliefs and Information
Questionnaire (SBIQ) [66],
Negative Thoughts During Sex
Questionnaire (NTDSQ) [67]
http://www.youngadultcancer
.ca/body-image-issues-are
-tough-but-worth-working-on/
VII. Sexual
History
and
Dating/
Couple
Experience
Assess if and how cancer
impacted:
○ Sexual experimentation and
experiences (number and type
of partners)
○ First sexual encounter and
anal/vaginal intercourse
○ Identification of sexual
preferences (partners and types
of sexually arousing activities)
For couples and partners,
consider high risk factors for
relationship loss or troubles
○ Consider the length of
relationship
○ Consider that the partner may
ill-equipped or not ready/willing
to take on the responsibilities
of the caregiver role
Cancer rehabilitation evaluation
system (CARES) Dating
Subscale [68]
Dyadic Adjustment Scale (DAS)
[69,70]
Personal Assessment of Intimacy
in Relationships (PAIR) [71]
http://ww.youngcancerspouses
.org
http://www.livestrong.org/
we-can-help/preparing-yourself/
communicating-with-your
-partner/
Understanding relationships,
sex, and fertility for young
people affected by cancer
booklet by Macmillan Cancer.
http://be.macmillan.org.uk/
be/p-298-relationships-sex
-and-fertility-for-young-people
-affected-by-cancer.aspx
*Validated instrument using AYAC as the population sample
**Validated instrument in oncology population
†Cancer Blogs from AYAC, relevant to all seven core domains
‡The Huffington Post’s hub of young adult cancer content, from recurring survivor blogs, to what’s new in the medical world
, Represents a “red-flag” tip for the clinician to asses
, Represents a self-report questionnaire
, Represents an online resource
, Represents a reading, e.g., a book, article or pamphlet
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[80–82]. The ﬁrst author’s own clinical experience
supports these ﬁndings, as infertility greatly
affected her patients’ abilities to form and maintain
meaningful relationships. Furthermore, single
AYAC patients often cited fertility issues as either a
barrier to dating, in that many often believed they
are less desirable as mates when compared with
same-aged available singles. Couple AYAC report
that fertility difﬁculties pose a serious threat to the
survival of existing relationships.
Study results conﬁrm that treatment effects
range from complete infertility to reduced or tem-
porary infertility for AYAC [50,51,83,84]. Discus-
sions of fertility risks prior to initiating treatment
are not routinely performed with AYAC [85–87].
As a result, AYAC lose the “window of time” where
fertility preservation must take place either
because they were never informed or options were
only presented to them too late in their treatment,
or often explained that treatment could not be
delayed. In other cases, fertility preservation was
not possible because the AYAC could not afford
fertility preservation. These aforementioned “let-
downs” can be discussed when the clinicians asks
about fertility.
A full, extensive review of the effects of treat-
ment on fertility among AYAC is beyond the scope
of this article [49,84]; however, the authors draw
attention to a number of fertility resources that
may assist the clinician’s understanding and assess-
ment of AYAC fertility issues and their subsequent
effects on sexuality (e.g. [51,83,88,89],). Addition-
ally, the clinician can ﬁrst review the clinical notes
from care-team members and fertility specialists
concerning past and upcoming cancer treat-
ment(s), and review their recommendations spe-
ciﬁc to the safety and timing of conception. In
cases where the status of an AYAC’s reproductive
functioning is unknown, the authors suggest that
the AYAC be referred to a fertility specialist.
Second, the provision of valuable AYAC-speciﬁc
websites and programs pertaining to fertility, such
as the LIVESTRONG’s Fertile Hope Program
and CanTeen, provides information and support
for both AYAC and clinicians. Third, to better
understand the scope of the emotional repercus-
sions of infertility, the FertilQol self-report ques-
tionnaire is recommended [48].
Parallel to assessing fertility, discussions con-
cerning safe sex practices provide a fruitful
opportunity to educate AYAC about the more
general beneﬁts of contraception, such as protec-
tion against STIs, unwanted pregnancies, and
post-chemotherapy side effects that can put both
partners at risk. As an example, clinicians may
inform older adolescents and young early adult-
hood AYAC about the human papillomavirus
(HPV), the most common STI, and the HPV
vaccine that prevents against cervical, head, and
neck cancers and HPV-associated diseases [90].
IV. Sexual Functioning
A comprehensive assessment should also include
inquiring about treatment-related effects on both
objective sexual functioning (e.g., physiological
arousal such as lubrication, orgasm, and ejacula-
tion) and subjective functioning (e.g., having desire,
experiencing pleasure and enjoyment). Special
attention should be paid to the direct negative
impacts of treatments on the genito-urinary, pelvic,
or hormonal areas (e.g., surgery to remove testes,
ovaries or cervix; pelvic or brain radiation near the
pituitary or thyroid glands; hormonal suppression
medications) [10,52,53]. Similarly, chemotherapy,
including allo/autostem cell transplants, can cause
adverse sexual effects such as low sexual desire,
delayed orgasm, and erectile dysfunction
[61,91,92]. To help rule out the direct treatment
impacts underlying sexual complaints, we recom-
mend referring AYAC to providers with a specialty
practice in gyno-oncology or uro-oncology.
Common sexual complaints of female AYAC
include lowered or loss of sexual desire or arousal,
problems with orgasm response (e.g., frequency
and intensity). Sexual complaints most commonly
reported by young women also include sexual pain
during penetration that may be associated with
treatment-induced structural changes to the labial/
vaginal areas (e.g., thinning/loss rugae, tightening,
shortening) [52,93–97]. For example, women with
breast cancer treated with hormonal ablation may
experience early menopause and are at risk for
facing a complete loss of desire and vaginal
atrophy [98–100]. Moreover, breast surgery can
often result in a signiﬁcant decrease in arousal
stemming from the loss of sensitivity in breast and
nipple areas. As a consequence, it is crucial for
clinicians to validate these young women’s sexual
distress and to provide them with literature such as
the Menopause Guidebook from the North
American Menopause Society [101]. For women
with gynecological cancers treated with surgery
(e.g., removal of the cervix) and/or brachytherapy,
treatment-induced changes may include altera-
tions in vaginal structure such as the depth, width,
elasticity, and consistency of the vaginal walls, all
of which are suspected causes of bleeding and pain
during intercourse [52,102]. Lastly, for women
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treated with hysterectomies, a signiﬁcant loss in
the intensity of their orgasm response may be
experienced mainly due to the loss of uterine con-
tractions [53,103–105].
Although the majority of young men do not
report changes in sexual function post-
chemotherapy, some have reported experiencing
short-term sexual impacts that are usually
resolved within the ﬁrst year following treatment
[106,107]. Domains of sexual functioning that
should be assessed in young men treated for
testicular cancer and lymphomas include lowered
sexual desire and difﬁculties in getting and/or
maintaining erections [108,109]. Changes in the
orgasm response may also be reported and are
likely attributable to a decrease in the ejaculate,
semen, and/or sensation of orgasm [106,110,111].
Despite being transient, any of these changes in
sexual functioning can signiﬁcantly threaten
men’s sense of masculinity and self/body image
and, in turn, also their sexual proactivity (e.g.,
seeking sexual partners and making sexual
advances) [50,109,112].
The degree of sexual side effects from cancer
on AYAC remains somewhat unknown mainly
due to scant research in sexual oncology (particu-
larly among the AYAC population). To obtain a
fuller clinical picture of the range of sexual con-
sequences for both women and men, we highly
recommend the health professional and patient
versions of booklets from the National Cancer
Institute [1], as well as the works by Ofman and
Brotto [52,53]. The model of predictive factors of
sexual health speciﬁc to women with breast
cancer by Ganz et al. [113] is also useful for iden-
tifying survivors at risk of developing sexual
problems.
V. Sexual Coping Style
Assessing an AYAC’s coping style in response to
cancer—speciﬁcally, how he or she deals with
sexual repercussions—needs to be assessed, as it
may maintain sexual difﬁculties and/or compro-
mise the development of the sexual self. An
AYAC’s passive or avoidant sexual coping style
should also be considered in relation to the cancer
continuum. Timing is thus a key determinant of an
AYAC’s willingness to address sexual impairments
as well as a key indicator of adaptive vs. maladap-
tive sexual avoidance. Avoiding sex to deal with the
stress of active treatment constitutes not only a
common, but also an adaptive coping response. As
such, the avoidance of sexual activities for years
beyond treatment not only maintains but worsens
sexual anxieties and poses a serious threat to the
developing sexual self of an AYAC.
Determining AYAC sexual coping styles may
also include inquiring about a range of negative/
avoidant strategies that reﬂect their unique sexual
realities. A passive coping style may include avoid-
ance strategies such as refraining from engaging in
sexual activities with or without the partner, the
use of technology (e.g., Internet and sexting) to
avoid partner-related sexual activities, and con-
sumption of potentially problematic substances to
either alleviate anxiety (e.g., alcohol and drugs) or
enhance sexual response (e.g., ecstasy) [114–116].
Asking about the frequency, context, and underly-
ing reasons for substance use tends to be a sensitive
area of questioning but presents the clinician with
an opportunity to combine sexual questioning with
education. As an example, the older adolescent
may not be informed about the potential adverse
effects of certain substances on sexual response
[114,115] and this thus presents an optimal
moment for the clinician to address and provide
resources for substance problems.
VI. Body and Self-Image
Changes in body/physical appearance from cancer
treatments constitute a major source of concern
and distress for AYAC [5,9,22,117–119]. Upsetting
changes may include hair loss, weight loss or gain,
and body disﬁgurements such as scarring and
asymmetry due to the loss or alteration of a body
part (e.g., breast or testicle) [18,74,117]. Any
visible physical changes may signiﬁcantly affect the
development of sexual self-esteem, including
delayed sexual maturation and formation of mean-
ingful couple relationships [18,85,118]. Indeed,
impaired body/self-image has been shown to not
only affect decision making about dating, but also
AYAC participation in social events, which provide
opportunities to engage in dating and sexual expe-
riences [4,18].
It is important for the clinician to assess an
AYAC’s frame of mind during sex, and more spe-
ciﬁcally to inquire about “sexual hypervigilence”
to an affected area (e.g., a scar, a missing body part)
as well as arousal and orgasm responses, as this
may trap the AYAC into a negative self-fulﬁlling
prophecy cycle [64–67]. Indeed, we found that
“sexual hypervigilance” not only distracted AYAC
attention to the negative, unarousing aspects of the
sexual encounter, but also inhibited their sexual
responses, thus reinforcing their fear of sexual per-
formance failure.
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VII. Sexual History and Dating/Couple Experience
Evaluating the impact of cancer on AYAC sexual
development includes examining how cancer can
alter the course of sexual experimentation, a key
component of sexual maturation and identity. We
recommend getting a snapshot of an AYAC’s
sexual life before cancer and, more speciﬁcally, his
or her repertoire of sexual experimentation. The
development of the sexual self takes place through
a range of sexual experiences, which occur either
alone or with a partner (including opposite and
same sex partners). For older adolescents and early
young adults, cancer may not only limit experi-
mentation with different sexual partners, but also
the experience of positive, sexually arousing, inti-
mate sexual relationships that are necessary in
order to build sexual self-esteem and conﬁdence
[18,118,120]. Our clinical reports conﬁrm study
results showing that AYAC signiﬁcantly differ
from their age-matched peers by reporting lower
sexual experience, lower self-esteem, and higher
sexual distress [18,93,120] .
Dating
Assessing the sexuality of the single AYAC places a
special emphasis on looking at the role of fear of
rejection on willingness to date and on its multiple
developmental repercussions. It is suggested to
examinehow fear of being rejectedmaydelay sexual
experimentation and dating and consequently the
formation of meaningful couple and sexual rela-
tionships. Moreover, AYAC’s greater sensitivity to
the fear of rejection, compared with aged-matched
peers without cancer, can bring about distinctive
dating fears and issues [1,18,74,112]. Older adoles-
cent and early adulthood AYAC dating fears may
differ from their peers due to disclosure regarding
their cancer history (e.g., when to bring it up and
how) [5,121], body image, and sexual dysfunctions
caused by cancer. Dating issues may be assessed
using the Comfort in Dating subscale of the
CARES questionnaire [68].
Couple Relationships
Evaluating couple relationship adjustment also
factors into the psychosexual development not
only of AYAC as individuals, but also as romantic
partners. Couple relationship factors play a critical
role in the emergence and maintenance of sexual
problems and may either facilitate or hinder AYAC
efforts at resuming their sex lives [10,53].
Our clinical reports conﬁrm study ﬁndings indi-
cating that only a small percentage of couples of all
ages with cancer separated or divorced following a
cancer diagnosis [122,123]. However, adolescent
and early young adulthood couples are at a higher
risk of experiencing a break-up compared with
healthy, age-matched couples [122]. In addition to
partners’ age, other risk factors to assess include the
degree of couple maturity (which we identiﬁed as
relationship duration), partner relationship skills,
and commitment prior to cancer. In our research,
we found a positive relationship between relation-
ship maturity and the likelihood that a relationship
will successfully cope with cancer. More speciﬁ-
cally, the longer the relationship prior to diagnosis,
as well as better partner skills and a higher level of
commitment, are positive predictors of relationship
surviveal [109,120,124].
Cancer not only disrupts the development of
the AYAC as an individual, but also the develop-
ment of the AYAC as a member of a couple. When
a member of a couple is diagnosed during the early
months or years of a relationship, cancer cuts short
or robs the AYAC couple of their “honeymoon”
phase. Instead, they are forced to adjust to a major
life event and to face a host of relationship changes
that may in turn trigger a range of emotional
repercussions. Among these, the fear of relation-
ship loss features as a predominant emotion that is
experienced by both partners. This is particularly
challenging for new relationships (e.g., ranging
from few months to 1–2 years), in which the part-
ners might feel “trapped” by the cancer, as they
may not have even felt secure/conﬁdent in the
relationship prior to diagnosis.
For the AYAC, the fear of relationship loss may
manifest as a fear of being rejected and guilt pro-
jected onto the “un-deserving partner.” This fear
can be further exacerbated when framed as the
availability of other healthy partners competing
for a relationship, another painful reality unique to
being young with cancer. For the AYAC’s partner,
sadness in conjunction with signiﬁcant anxiety
may be experienced at the thought of losing the
AYAC to death [53]. Although rarely expressed by
the partner, this fear may be at the forefront of the
his or her mind, or manifest itself as a distant
thought. Also, the partner may feel helpless for not
being able to help his or her loved one, or from
wanting to escape his or her current couple reality,
which can include thoughts of ending the relation-
ship. It is not uncommon for the partner to feel
guilty for being “the healthy one.” These issues are
often inﬂuenced by the patient’s age, diagnosis
(e.g., Stage 1 vs. Stage 4), and the age of the rela-
tionship (i.e., the time the couple has been
together).
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Irrespective of age, most couples affected by
cancer experience the post-cancer dyadic role–shift
from spouse/lover to patient/caregiver, which con-
stitutes an exceptionally challenging adjustment
period. This is especially difﬁcult for the younger
AYAC couple [62,63]. The adolescent and early
young adulthood AYAC partner may feel over-
whelmed, ill-equipped, or simply not ready/willing
to take on the responsibilities of the caregiver role.
It is possible that in young, budding couples, the
partner decides to forego the relationship. Conse-
quently, it is vital to assess partners’ reactive coping
to the responsibilities of the patient/caregiver roles
and to the changes in their couple intimacy and
sexuality.
Shifting to the patient/caregiver roles can also
signiﬁcantly alter the sex lives of the young
AYAC couple. Besides the obvious, disease-related
reasons, the sharp drop in the frequency of sexual
activities may be explained by the sexually
“unarousing” roles of being a patient and a care-
giver [53]. Giving and receiving illness-related care
steers partners’ attention away from themselves as
spouses/lovers and may alter their perceptions as
sexual selves, increasing the likelihood of sexual
avoidance. For the AYAC, being identiﬁed as a
patientmay evoke feelings of asexuality or an inher-
ent sense that he or she have lost all desirability as a
sexual partner.
Interestingly, some couples (likely among late
early adulthood AYAC) ﬁnd resilience by working
together to ﬁght cancer, which strengthens the
couple’s intimacy both subjectively (i.e., how close
or connected they feel to each other) and physi-
cally (e.g., how they mutually engage in physical
displays of affection and love) [50,109,123,125].
Moreover, greater intimacy may positively impact
an AYAC sex life. Our clinical reports validate
study ﬁndings indicating that couples reporting a
strong, intimate connection were more likely to
develop alternate, non-performance–based sexual
activities and to derive pleasure from these activi-
ties [10,53,62,109,126,127].
A number of questionnaires are currently avail-
able to assess either couple adjustment (e.g.,
Dyadic Adjustment Scale [69,70]) or couple inti-
macy (e.g., the Personal Assessment of Intimacy in
Relationships [71]).
Conclusion
AYAC are now recognized as a distinctive popu-
lation with unique biomedical as well as psycho-
social needs [2,6,19,23]. Cancer not only disrupts
the development of AYAC as emerging adults but
also as emerging sexual adults. AYAC face a host
of cancer repercussions that affect multiple areas
closely tied to their sexuality, and as a result delay
their psychosexual development. The cancer
experience directly affects fertility; sexual func-
tioning; body and self image; and dating and
couple relationships.
It is thus important to tailor the clinical assess-
ment to capture the special, distinctive sexual
needs of this population, which will allow for more
tailored interventions. On the basis of existing
AYAC-speciﬁc clinical guidelines and recommen-
dations, the main objective of this article was to
present a tailored approach to assessing the sexu-
ality of AYAC and the core domains that are
important to assess. Furthermore, it is extremely
beneﬁcial to assess sexuality and consider the
unique concerns among AYAC rather than to treat
all cancer patients in cookbook fashion based on
cancer site norms. The article also aimed at pre-
senting speciﬁc resources and clinical tools to
either assist the clinician or act as direct resources
for their AYAC patients. Bringing attention to the
unique needs of the AYAC population can ideally
impact provision of the best quality of patient care.
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